Clinical Trials Logo

Diabetes Mellitus, Type 2 clinical trials

View clinical trials related to Diabetes Mellitus, Type 2.

Filter by:

NCT ID: NCT05124834 Completed - Diabetes Mellitus Clinical Trials

System Accuracy of the Blood Glucose Monitor for Personal Use JT100

Start date: January 15, 2022
Phase: N/A
Study type: Interventional

This study assesses the system accuracy a blood glucose monitoring systems pursuant to ISO 15197

NCT ID: NCT05124457 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

DETERMINE: Detemir vs NPH

DETERMINE
Start date: February 1, 2022
Phase: Phase 2
Study type: Interventional

The purpose of the study is to compare rates of neonatal hypoglycemia with maternal NPH vs determir use.

NCT ID: NCT05124405 Suspended - Cancer Clinical Trials

Monitoring Your Exercise-related Metrics Over Time Via Wearable Electronic Devices

Start date: May 24, 2018
Phase: N/A
Study type: Interventional

To test the use of a continuous activity and heart rate tracker (Fitbit) and continuous glucose monitor (CGM) in monitoring daily exercise-related activities.

NCT ID: NCT05120544 Active, not recruiting - Hypertension Clinical Trials

Expanding Technology-Enabled Nurse Delivered Chronic Disease Care

EXTEND
Start date: April 21, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate whether the self-management of diabetes and hypertension can be improved with the use of mobile monitoring devices and nursing support.

NCT ID: NCT05118061 Completed - Diabetes Mellitus Clinical Trials

StatStrip Glucose/Ketone Meter System Ketone Evaluation

Start date: May 25, 2022
Phase:
Study type: Observational

The Nova StatStrip Glucose / Ketone Meter System is a fast, simple, whole blood system that can be used to quantify both glucose and ketones using two distinct test strips. This Protocol will describe an evaluation of the system's Ketone performance only. Ketone testing methods that quantify beta-hydroxybutyrate (β-OHB), the predominant ketone body, are used for diagnosing and monitoring ketoacidosis, a life-threatening complication of hyperglycemia. The performance of the StatStrip Ketone test strip using the Nova StatStrip Glucose / Ketone Hospital Meter System on venous and capillary whole blood will be assessed.

NCT ID: NCT05117424 Recruiting - Obesity Clinical Trials

CArdioMetabolism and Atherosclerotic PlaqUe progreSsion

CAMPUS
Start date: November 1, 2018
Phase:
Study type: Observational [Patient Registry]

Systematic metabolic diseases are closely related to prevalence and progression of atherosclerosis. This prospective cohort consecutively enrolls patients with coronary artery disease compliacted with metabolic abnormalities such as diabtetes, prediabetes, obesity, chronic kidney disease and hyperuricemia.

NCT ID: NCT05116319 Completed - Diabetes Mellitus Clinical Trials

Prediction to Detect Pre-DM/DM in a Chinese Population

Start date: February 1, 2022
Phase:
Study type: Observational

This project will compare the sensitivity and specificity of different screening criteria or recommendations to detect pre-diabetes or diabetes mellitus in a Chinese population, using point-of-care hemoglobin A1c.

NCT ID: NCT05115682 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Circadian Rhythm and Metabolic Effects of Exercise

HITMet
Start date: November 10, 2021
Phase: N/A
Study type: Interventional

Physical exercise is efficacious in controlling blood glucose levels in individuals with Type 2 diabetes. An individual's exercise capacity and ability to utilize glucose as an energy source oscillates throughout the day. Hence, the beneficial effects of exercise on blood glucose levels may depend on the time of day when the exercise bout is performed. However, the time of day in which the most beneficial adaptations to exercise can be achieved remains unknown. This project aims to answer the following questions: Does time of day impact the beneficial effects of exercise on blood glucose? If so, when can the most beneficial effects of exercise be achieved? Which metabolic mechanisms links time of day, exercise and blood glucose control? To address these questions, individuals with or without Type 2 diabetes will perform an exercise session at two different times (09:00 and 16:00), and continuous glucose monitoring will be used to assess the effects of exercise on blood glucose. We will determine the specific metabolic processes which promote the most beneficial blood glucose response. To achieve this, we will measure which metabolic substrates (carbohydrates, lipids and proteins) are used and which metabolites produced in blood, skeletal muscle and adipose tissue in response to exercise at different times of the day.

NCT ID: NCT05115188 Recruiting - Clinical trials for Diabetes, Gestational

DIAgnosing GDM usiNg Oral Sugar InStead

DIAGNOSIS
Start date: October 1, 2022
Phase: Phase 2
Study type: Interventional

The purpose of this study is to compare the positive and negative effects of Dex4® tablets, as an alternative form of fast acting carbohydrate, compared to the current standard diagnostic test, glucose beverage. The investigators hypothesis that because of their availability in solid, chewable form, variety of flavours and lack of carbonation, Dex4® tablets may result in fewer side effects than glucose beverage and provide an equivalent carbohydrate challenge for diagnosis of gestational diabetes.

NCT ID: NCT05115175 Completed - Clinical trials for Diabetes Mellitus, Type 1

Acceptability of Self-Led Mindfulness-Based Intervention

Start date: July 14, 2019
Phase: N/A
Study type: Interventional

This study had two primary aims. First, the investigators examined the associations between mindfulness and diabetes-related outcomes. It was hypothesized that at baseline, increased mindfulness would be associated with decreased diabetes distress and more optimal glycemic levels and that all three variables would share similar associations with related constructs including greater self-compassion, lower general stress, better psychosocial health, increased diabetes treatment engagement, and greater diabetes-related quality of life. The association between specific aspects of dispositional mindfulness and diabetes distress was also explored. Second, the investigators examined the acceptability, feasibility, and potential utility of self-led MBSR intervention. It was hypothesized that participation in a self-led MBSR intervention would be feasible and acceptable, evidenced by treatment attrition and participant feedback. It was also hypothesized that participants who received the self-led Mindfulness-based stress reduction (MBSR) intervention would experience increased mindfulness and decreased diabetes distress compared to a waitlist control group.